AA
Andreas Argyrides Oppenheimer Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
32
Avg Return
Past Year
Past Year
13%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past 3 Months
Positive
83.3%
Neutral
0%
Negative
16.7%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
| Stock | Rating | Price Target |
Upside Downside |
Ratings 3 Months |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Outperform
Initiated
| $10 |
74%
upside
| 1 | +2.8% |
0
%
| 16 Mar ‘26 1 month ago |
|
|
|
Underperform
Maintained
| $19 |
52%
downside
| 1 | -48% |
0
%
| 12 Mar ‘26 1 month ago |
|
|
|
Outperform
Maintained
| $3 |
573%
upside
| 1 | -20% |
0
%
| 5 Mar ‘26 1 month ago |
|
|
|
Outperform
Maintained
| $600 |
2%
upside
| 1 | +20% |
0
%
| 26 Feb ‘26 1 month ago |
|
|
|
Outperform
Maintained
| $35 |
91%
upside
| 1 | -10% |
0
%
| 24 Feb ‘26 1 month ago |
|
|
|
Outperform
Initiated
| $42 |
53%
upside
| 1 | +28% |
0
%
| 22 Jan ‘26 2 months ago |
|